These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2488236)

  • 1. Tumor progression stage: specific losses of heterozygosity.
    Cavenee WK
    Princess Takamatsu Symp; 1989; 20():33-42. PubMed ID: 2488236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitotic abnormalities leading to cancer predisposition and progression.
    Cavenee WK
    Cancer Detect Prev; 1989; 14(2):269-73. PubMed ID: 2559800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of genetic defects during astrocytoma progression.
    Cavenee WK
    Cancer; 1992 Sep; 70(6 Suppl):1788-93. PubMed ID: 1325281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of human cancer predisposition and progression.
    Cavenee WK; Scrable HJ; James CD
    Mutat Res; 1991 Apr; 247(2):199-202. PubMed ID: 2011137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal genomic alterations in glioma malignancy stages.
    James CD; Carlbom E; Dumanski JP; Hansen M; Nordenskjold M; Collins VP; Cavenee WK
    Cancer Res; 1988 Oct; 48(19):5546-51. PubMed ID: 2901288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
    Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
    Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal mechanisms in the initiation of human familial mixed cancers.
    Cavenee WK
    Princess Takamatsu Symp; 1986; 17():171-9. PubMed ID: 3332009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression.
    Rempel SA; Schwechheimer K; Davis RL; Cavenee WK; Rosenblum ML
    Cancer Res; 1993 May; 53(10 Suppl):2386-92. PubMed ID: 8485725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor suppressor genes].
    Kohno T; Yokota J
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1265-73. PubMed ID: 8392829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines.
    Roversi G; Pfundt R; Moroni RF; Magnani I; van Reijmersdal S; Pollo B; Straatman H; Larizza L; Schoenmakers EF
    Oncogene; 2006 Mar; 25(10):1571-83. PubMed ID: 16247447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic events unmask recessive cancer genes to initiate malignancy.
    Gallie BL; Worton RG
    J Cell Biochem; 1986; 32(3):215-22. PubMed ID: 3023409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple genetic alterations in small-cell lung carcinoma.
    Yokota J; Mori N; Akiyama T; Shimosato Y; Sugimura T; Terada M
    Princess Takamatsu Symp; 1989; 20():43-8. PubMed ID: 2577337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low incidence of loss of chromosome 10 in sporadic and hereditary human medullary thyroid carcinoma.
    Nelkin BD; Nakamura Y; White RW; de Bustros AC; Herman J; Wells SA; Baylin SB
    Cancer Res; 1989 Aug; 49(15):4114-9. PubMed ID: 2568166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of bacterial artificial chromosome array-based comparative genomic hybridization and spectral karyotyping to the analysis of glioblastoma multiforme.
    Cowell JK; Matsui S; Wang YD; LaDuca J; Conroy J; McQuaid D; Nowak NJ
    Cancer Genet Cytogenet; 2004 May; 151(1):36-51. PubMed ID: 15120909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current knowledge of heritable tumors.
    Cavenee WK
    Birth Defects Orig Artic Ser; 1989; 25(2):29-43. PubMed ID: 2655740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gliomas.
    Collins VP
    Cancer Surv; 1998; 32():37-51. PubMed ID: 10489622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor suppressor genes. New perspectives for clinical investigations in cancer].
    Paván J; Gualandi F; Rimessi P; Corallini A; Barbanti-Brodano G
    Medicina (B Aires); 1994; 54(2):163-8. PubMed ID: 7997135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional evidence for the presence of tumor suppressor genes on the short arm of chromosome 10 in human gliomas.
    Kon H; Sonoda Y; Kumabe T; Yoshimoto T; Sekiya T; Murakami Y
    Oncogene; 1998 Jan; 16(2):257-63. PubMed ID: 9464544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.